Challenges and Prospects of Allogeneic CAR-T Cell Therapy
Time: 9:00 am - 12:00 pm
Whilst most success in CAR-T therapies is currently seen in the autologous space we are seeing a drive for progress in allogeneic CAR-T therapies.
Join us as we discuss:
- Design for allo-CAR-T
- Safety issue for Allo-CAR-T
- Allo-CAR-T and its manufacture
- Features and applications of uCAR-T